As a flexible Contract Technology Development and Manufacturing Organization (CTDMO), OrganaBio provides flexible, integrated supply chains, process development, and manufacturing resources with extensive technical knowledge and comprehensive quality and regulatory support. OrganaBio is committed to strengthening and accelerating the deployment and commercialization of cell-based therapies by simplifying tech transfer and scale-up between pre-clinical and translational phases through customizable, end-to-end solutions in cGMP manufacturing.